These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15373656)

  • 1. Review: platelet matching for alloimmunized patients--room for improvement.
    Nance ST; Hsu S; Vassallo RR; Murphy S
    Immunohematology; 2004; 20(2):80-8. PubMed ID: 15373656
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet crossmatching with Capture P: clinical relevance.
    Böck M; Heim MU; Schleich I; Weindler R; Wagner M; Mempel W
    Infusionstherapie; 1989 Aug; 16(4):183-5. PubMed ID: 2807565
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet transfusions.
    Stroncek DF; Rebulla P
    Lancet; 2007 Aug; 370(9585):427-38. PubMed ID: 17679020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random donor platelet cross-matching.
    Freedman J
    Curr Stud Hematol Blood Transfus; 1986; (52):65-70. PubMed ID: 3698687
    [No Abstract]   [Full Text] [Related]  

  • 6. The case of the perplexing platelet product.
    Eisenberg S
    ONS Connect; 2012 Jul; 27(7):26. PubMed ID: 22855988
    [No Abstract]   [Full Text] [Related]  

  • 7. Solid phase platelet crossmatching versus complement dependent lymphocytotoxicity--clinical utility.
    Lane D; Shivji S; Turner AR
    Prog Clin Biol Res; 1990; 337():59-62. PubMed ID: 2353019
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion of apheresis platelets and ABO groups.
    Vox Sang; 2005 Apr; 88(3):207-21. PubMed ID: 15787735
    [No Abstract]   [Full Text] [Related]  

  • 9. First results with Capture-P, a solid phase immunoassay for the detection of platelet antibodies.
    Mayr WR; de Wit M; Gassner H; Hahn M; Goertz-Kaiser B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):459-61. PubMed ID: 2480290
    [No Abstract]   [Full Text] [Related]  

  • 10. Flow-cytometric screening of platelet antibodies with previously frozen cells.
    Döhlinger S; Humpe A; Connor J; Köhler M; Legler TJ
    J Immunol Methods; 2005 Feb; 297(1-2):169-75. PubMed ID: 15777940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretic and practical aspects of platelet crossmatching.
    von dem Borne AE; Ouwehand WH; Kuijpers RW
    Transfus Med Rev; 1990 Oct; 4(4):265-78. PubMed ID: 2134633
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet crossmatch tests using radiolabelled staphylococcal protein A or peroxidase anti-peroxidase in alloimmunized patients.
    Yam P; Petz LD; Scott EP; Santos S
    Br J Haematol; 1984 Jun; 57(2):337-47. PubMed ID: 6375714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing platelet transfusion therapy.
    Heal JM; Blumberg N
    Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
    Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
    Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cross matching test (including lymphocyte cross matching test, platelet cross matching test)].
    Okuda M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():782-7. PubMed ID: 20942189
    [No Abstract]   [Full Text] [Related]  

  • 17. Flow cytometric analysis in platelet crossmatching using a platelet suspension immunofluorescence test.
    Skogen B; Christiansen D; Husebekk A
    Transfusion; 1995 Oct; 35(10):832-6. PubMed ID: 7570913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO incompatible platelets: risks versus benefit.
    Dunbar NM; Ornstein DL; Dumont LJ
    Curr Opin Hematol; 2012 Nov; 19(6):475-9. PubMed ID: 22914587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization by platelet transfusion.
    Brand A
    Schweiz Med Wochenschr; 1991 Mar; 121(13):467-9. PubMed ID: 2031162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.